Latest From Biotech Now

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

72263479

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in total transactions, including $53 billion in partnering deals, $16.5 billion in venture investments and 133 IPOs. According to the 2015 Campbell Alliance Dealmakers’ Intentions Study, 2015 is shaping up to be the year of historic M&A in the biopharmaceutical sector, driven in part by greater access to capital. The partnering numbers at BIO 2015 further indicate that the appetite for Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from whether to take the risk of entering a new area at all to whether and how to partner strategically with another company. It’s a challenge for both the biggest biopharma companies and emerging biotechs to evaluate how and when to enter new therapeutic areas and to try to ensure that their efforts will not only help patients in need but Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

How to Grow a Sustainable Biotech Company? Three Success Stories

Sustainable Biotech Company

Katrine Bosley, CEO of Editas Medicine kicked off the session by introducing panelists from three biotech firms with drug candidates in various stages: Arndt Schottelius, CDO of MorphoSys,  Loredana Ablondi, Licensing Manager of Chiesi Farmaceutici SpA (Cheisi) and Andre Hoekema, Senior Vice President of Corporate Development at Galapagos NV. The panelists spoke about the importance of critical alliances which enabled them to grow their companies, and the possibilities that emerged from them. For MorphaSys, this Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Scientific American WorldView Super Session and the Future of Innovation

FullSizeRender1

The final Super Session of the 2015 BIO International Convention today featured a panel of international luminaries who offered their perspective on the future of innovation. Moderated by television and radio journalist, David Brancaccio, host of Marketplace Morning Report, the panelists provided a fresh perspectives on international life science development and the ways disruptive technologies are changing how we do business and experience the world around us. On the panel: Lee Hood, President of Institute Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Closing-Day Recap of BIO 2015: What the Official Bloggers Have to Say

Everyday during the BIO International Convention our BIO Official Bloggers, writers who are on top of the biotechnology beat, release statements about their experience at the BIO International Convention. Here is what they have to say about the closing day: Genomics Blog By Mike Spear You probably snore when you’re asleep.  45% of the population in the UK and the EU snore and 64% of American households have someone who snores. It is generally irritating Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,